The tweet was deleted by the author.
But we saved everything 🙂.
Solid Biosciences Inc. has announced its sponsorship of the Jett Foundation's 25th Anniversary Silver Soirée, set for June 11.
The company expressed its continued commitment as a longstanding partner of the foundation, which focuses on improving the lives of individuals and families impacted by Duchenne muscular dystrophy. Solid Biosciences Inc. reaffirmed its support for the foundation’s initiatives in the field, highlighting the shared goal of making a meaningful difference through community events and advocacy.
Solid Biosciences recently presented clinical insights on its SGT-003 gene therapy candidate for Duchenne muscular dystrophy at a leading scientific congress, according to a company update. The company is also set to participate in the Jefferies Global Healthcare Conference, where CEO Bo Cumbo will lead a fireside chat on June 3, as outlined in a recent announcement. Both engagements reflect Solid Biosciences’ ongoing activity in the sector.